Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Title: Cereblon (CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium
Author(s): Iskierka-Jazdzewska, Elzbieta; Stepien, Anna; Canzian, Federico; et al.
Source: Blood Volume: 124 Issue: 21 Published: 2014
Times Cited: 0